<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03535571</url>
  </required_header>
  <id_info>
    <org_study_id>18PEHH</org_study_id>
    <nct_id>NCT03535571</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females</brief_title>
  <official_title>A Proof-of-concept Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hofseth Biocare ASA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KGK Science Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hofseth Biocare ASA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the efficacy of Salmon Protein Hydrolysate Powder
      (CollaGo®) on energy increase and anti-inflammatory modulation in healthy males and females.
      Eligible participants will be asked to consume 1 sachet of CollaGo for 128 days and keep a
      study diary. Assessments will be measured at the randomization visit, and the end of study
      visit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 5, 2018</start_date>
  <completion_date type="Actual">October 23, 2018</completion_date>
  <primary_completion_date type="Actual">October 23, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Change From Baseline (Day 0) to End-of-study (Day 128) in Energy Level After a 128-day Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>This questionnaire consists of a total of 30 questions that assess vitality and quality of life. The responses for these questions range from 1 to 7, where 1 indicates &quot;never&quot; or &quot;not at all true&quot; 4 indicates &quot;sometimes&quot; or &quot;somewhat true&quot; and 7 indicates &quot;always&quot; or &quot;very true&quot; depending on the item that is assessed by the question.
15 of the 30 questions are positively keyed in which a higher score indicates a better outcome and remaining 15 questions are negatively keyed where a lower score indicates a better outcome. The responses on the negatively keyed questions will be reversed prior to calculating the total score (i.e. a response of 1 will be considered as 7, 2 will be considered as 6, etc.). Total range will be 30-210, where a higher total score indicates a better outcome and a lower total score indicates a worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Red Blood Cell (RBC) Count After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Mean Corpuscular Volume (MCV) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Mean Corpuscular Hemoglobin (MCH) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Mean Corpuscular Hemoglobin Concentration (MCHC) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Hematocrit After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Red Cell Distribution Width (RDW) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Hemoglobin (Hb) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Relative Expression of 84 Stress Genes After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Evaluated by oxidative stress-related gene RT Profiler PCR array. Seven of the 84 genes were upregulated, which are highlighted in the results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Total Reactive Oxygen Species/Reactive Nitrogen Species Free Radical Activity After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Assessed by ROS/RNS assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-1 Alpha After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-4 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-6 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-10 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-11 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-13 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine TGF-Beta After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>Measured by the Multi-Analyte ELISArray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Glycated Hemoglobin (HbA1c) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Day 128 in Fasting Glucose After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Score of the Hair, Nails, and Skin Self-Assessment Questionnaire After 128-day Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
    <description>This questionnaire consists of a total of 7 questions that assess the participant`s perception on hair (4 questions), nail (1 question) and skin health (2 question). The response to each question can range from 1 to 6 where 1 indicates &quot;greatly satisfied&quot; and 6 indicates &quot;greatly dissatisfied&quot;.
The range for the total score on this questionnaire is 7-42. Lower total score indicates a better outcome, and higher total score indicates a worse outcome.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The Incidence of Adverse Events Following a 128-day Supplementation</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Effect of a 128-day Supplementation on Weight</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Effect of a 128-day Supplementation on Blood Pressure</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Effect of a 128-day Supplementation on Heart Rate</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Effect of a 128-day Supplementation on Waist Circumference</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>The Effect of a 128-day Supplementation on Hip Circumference</measure>
    <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Salmon Protein Hydrolysate (CollaGo®)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Salmon Protein Hydrolysate</intervention_name>
    <description>4g of salmon protein hydrolysate per serving.</description>
    <arm_group_label>Salmon Protein Hydrolysate (CollaGo®)</arm_group_label>
    <other_name>CollaGo®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy male or female, 30-60 years of age

          2. Female participant is not of child bearing potential, defined as females who have had
             a hysterectomy or oophorectomy, bilateral tubal ligation or are post-menopausal
             (natural or surgically with &gt; 1 year since last menstruation) or,

             Females of childbearing potential must agree to use a medically approved method of
             birth control and have a negative urine pregnancy test result. All hormonal birth
             control must have been in use for a minimum of three months. Acceptable methods of
             birth control include:

               -  Hormonal contraceptives including oral contraceptives, hormone birth control
                  patch (Ortho Evra), vaginal contraceptive ring (NuvaRing), injectable
                  contraceptives (Depo-Provera, Lunelle), or hormone implant (Norplant System)

               -  Double-barrier method

               -  Intrauterine devices

               -  Non-heterosexual lifestyle or agrees to use contraception if planning on changing
                  to heterosexual partner(s)

               -  Vasectomy of partner (shown successful as per appropriate follow-up)

          3. BMI of 18.5 kg/m²-32.5 kg/m²

          4. Agrees to comply with study procedures

          5. Willing to commit to taking product for 128 days

          6. Agrees to provide voluntary, written, informed consent to participate in the study

          7. Agrees to maintain normal diet and exercise routine throughout the study

          8. Healthy as determined by medical history, medical physical test for good health, and
             laboratory results

        Exclusion Criteria:

          1. Women who are pregnant, breastfeeding, or planning to become pregnant during the trial

          2. Blood donation during or within 30 days of the last study visit

          3. Taking any specific energy supplements or vitamins at least 1 month prior to and
             during the trial as assessed by the QI

          4. Unstable weight for the last 2 months prior to the study assessed case by case by QI

          5. Individuals on a low protein diet

          6. Excessive consumption of alcohol equivalent to &gt;2 alcoholic drinks/day

          7. Use of marijuana assessed case by case by QI

          8. Known allergy to the test material's active or inactive ingredients

          9. Clinically significant abnormal Physical Examination results at screening

         10. Participation in clinical trials in the past 30 days

         11. Cognitively impaired and/or unable to give informed consent

         12. current cardiovascular disorders or uncontrolled blood pressure will be assessed by
             QI)

         13. Verbal confirmation of history of or current diagnosis of bleeding/blood disorder

         14. Verbal confirmation of Type I or Type II diabetes

         15. Verbal confirmation of kidney disease

         16. Verbal confirmation of history of liver disease

         17. Anemia based on hemoglobin and hematocrit at screening

         18. Thyroid disease assessed case by case by QI

         19. Iron Supplementation

         20. Mood stabilizers assessed case by case by QI

         21. Energy boosting supplements

         22. Individuals on workout supplements

         23. Habitual users of energy drinks

         24. Melatonin supplementation assessed case by case by QI

         25. Autoimmune disease or if immune-compromised (i.e. HIV positive, use of anti-rejection
             medication, rheumatoid arthritis, Hepatitis B/C positive)

         26. Surgical procedures which may impact the study outcomes within the past 3 months to be
             assessed by the QI

         27. Cancer, except skin cancers completely excised with no chemotherapy or radiation with
             a follow up that is negative. Volunteers with cancer in full remission will be
             assessed by the QI for inclusion.

         28. Presence or history of neurological disorders or significant psychiatric illness as
             assessed by QI

         29. Any other condition, in the QI's opinion, which may adversely affect the participant's
             ability to complete the study or its measures or which may pose significant risk to
             the participant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Crowley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KGK Science Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KGK Science Inc.</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 14, 2018</study_first_submitted>
  <study_first_submitted_qc>May 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2018</study_first_posted>
  <results_first_submitted>March 27, 2019</results_first_submitted>
  <results_first_submitted_qc>July 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 19, 2019</results_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Energy increase</keyword>
  <keyword>Energy</keyword>
  <keyword>Healthy</keyword>
  <keyword>anti-inflammatory</keyword>
  <keyword>Open-label</keyword>
  <keyword>Salmon protein</keyword>
  <keyword>Natural health product</keyword>
  <keyword>Dietary supplement</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT03535571/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Salmon Protein Hydrolysate (CollaGo)</title>
          <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Salmon Protein Hydrolysate (CollaGo)</title>
          <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.45" spread="5.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>African or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>East Asian or South East Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Western or Eastern European White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Change From Baseline (Day 0) to End-of-study (Day 128) in Energy Level After a 128-day Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <description>This questionnaire consists of a total of 30 questions that assess vitality and quality of life. The responses for these questions range from 1 to 7, where 1 indicates &quot;never&quot; or &quot;not at all true&quot; 4 indicates &quot;sometimes&quot; or &quot;somewhat true&quot; and 7 indicates &quot;always&quot; or &quot;very true&quot; depending on the item that is assessed by the question.
15 of the 30 questions are positively keyed in which a higher score indicates a better outcome and remaining 15 questions are negatively keyed where a lower score indicates a better outcome. The responses on the negatively keyed questions will be reversed prior to calculating the total score (i.e. a response of 1 will be considered as 7, 2 will be considered as 6, etc.). Total range will be 30-210, where a higher total score indicates a better outcome and a lower total score indicates a worse outcome.</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Change From Baseline (Day 0) to End-of-study (Day 128) in Energy Level After a 128-day Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <description>This questionnaire consists of a total of 30 questions that assess vitality and quality of life. The responses for these questions range from 1 to 7, where 1 indicates &quot;never&quot; or &quot;not at all true&quot; 4 indicates &quot;sometimes&quot; or &quot;somewhat true&quot; and 7 indicates &quot;always&quot; or &quot;very true&quot; depending on the item that is assessed by the question.
15 of the 30 questions are positively keyed in which a higher score indicates a better outcome and remaining 15 questions are negatively keyed where a lower score indicates a better outcome. The responses on the negatively keyed questions will be reversed prior to calculating the total score (i.e. a response of 1 will be considered as 7, 2 will be considered as 6, etc.). Total range will be 30-210, where a higher total score indicates a better outcome and a lower total score indicates a worse outcome.</description>
          <population>Intent to treat population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.89" spread="20.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Red Blood Cell (RBC) Count After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Red Blood Cell (RBC) Count After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>cells x10^12/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Mean Corpuscular Volume (MCV) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Mean Corpuscular Volume (MCV) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>fL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="2.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Mean Corpuscular Hemoglobin (MCH) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Mean Corpuscular Hemoglobin (MCH) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>pg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Mean Corpuscular Hemoglobin Concentration (MCHC) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Mean Corpuscular Hemoglobin Concentration (MCHC) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.65" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Hematocrit After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Hematocrit After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>L/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Red Cell Distribution Width (RDW) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Red Cell Distribution Width (RDW) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>percent change in size</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.79" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Hemoglobin (Hb) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Hemoglobin (Hb) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="7.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Relative Expression of 84 Stress Genes After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <description>Evaluated by oxidative stress-related gene RT Profiler PCR array. Seven of the 84 genes were upregulated, which are highlighted in the results.</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Relative Expression of 84 Stress Genes After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <description>Evaluated by oxidative stress-related gene RT Profiler PCR array. Seven of the 84 genes were upregulated, which are highlighted in the results.</description>
          <population>Intent to treat population</population>
          <units>Fold change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>APOE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.60" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FTH1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.73" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GCLC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.64" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GPX1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.96" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HMOX1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.10" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NQO1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.12" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SOD1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.06" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Total Reactive Oxygen Species/Reactive Nitrogen Species Free Radical Activity After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <description>Assessed by ROS/RNS assay</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Total Reactive Oxygen Species/Reactive Nitrogen Species Free Radical Activity After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <description>Assessed by ROS/RNS assay</description>
          <population>Intent to treat population</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-1 Alpha After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
        <description>Measured by the Multi-Analyte ELISArray</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-1 Alpha After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
          <description>Measured by the Multi-Analyte ELISArray</description>
          <population>Intent to treat population</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-4 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
        <description>Measured by the Multi-Analyte ELISArray</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-4 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
          <description>Measured by the Multi-Analyte ELISArray</description>
          <population>Intent to treat population</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-6 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
        <description>Measured by the Multi-Analyte ELISArray</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-6 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
          <description>Measured by the Multi-Analyte ELISArray</description>
          <population>Intent to treat population</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-10 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
        <description>Measured by the Multi-Analyte ELISArray</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-10 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
          <description>Measured by the Multi-Analyte ELISArray</description>
          <population>Intent to treat population</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.39" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-11 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
        <description>Measured by the Multi-Analyte ELISArray.</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>This measure was not included in the Multi-Analyte ELISArray analysis, therefore there is no data to report.</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo)</title>
            <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-11 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
          <description>Measured by the Multi-Analyte ELISArray.</description>
          <population>This measure was not included in the Multi-Analyte ELISArray analysis, therefore there is no data to report.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-13 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
        <description>Measured by the Multi-Analyte ELISArray</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine IL-13 After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®).</title>
          <description>Measured by the Multi-Analyte ELISArray</description>
          <population>Intent to treat population</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine TGF-Beta After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <description>Measured by the Multi-Analyte ELISArray</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>This measure was not included in the Multi-Analyte ELISArray analysis, therefore there is no data to report.</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo)</title>
            <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Levels of Human Inflammatory Cytokine TGF-Beta After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <description>Measured by the Multi-Analyte ELISArray</description>
          <population>This measure was not included in the Multi-Analyte ELISArray analysis, therefore there is no data to report.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Glycated Hemoglobin (HbA1c) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Glycated Hemoglobin (HbA1c) After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>percentage of glucose bound to RBCs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Day 128 in Fasting Glucose After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Day 128 in Fasting Glucose After Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <population>Intent to treat population</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Score of the Hair, Nails, and Skin Self-Assessment Questionnaire After 128-day Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
        <description>This questionnaire consists of a total of 7 questions that assess the participant`s perception on hair (4 questions), nail (1 question) and skin health (2 question). The response to each question can range from 1 to 6 where 1 indicates &quot;greatly satisfied&quot; and 6 indicates &quot;greatly dissatisfied&quot;.
The range for the total score on this questionnaire is 7-42. Lower total score indicates a better outcome, and higher total score indicates a worse outcome.</description>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Score of the Hair, Nails, and Skin Self-Assessment Questionnaire After 128-day Supplementation With Collagenic Salmon Protein Hydrolysate Powder (CollaGo®)</title>
          <description>This questionnaire consists of a total of 7 questions that assess the participant`s perception on hair (4 questions), nail (1 question) and skin health (2 question). The response to each question can range from 1 to 6 where 1 indicates &quot;greatly satisfied&quot; and 6 indicates &quot;greatly dissatisfied&quot;.
The range for the total score on this questionnaire is 7-42. Lower total score indicates a better outcome, and higher total score indicates a worse outcome.</description>
          <population>Intent to treat population</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.74" spread="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Incidence of Adverse Events Following a 128-day Supplementation</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Frequency Threshold for Reporting Other Adverse Events: 5%. Full information can be found in the adverse events section. Summary can be found below.</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo)</title>
            <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Incidence of Adverse Events Following a 128-day Supplementation</title>
          <population>Frequency Threshold for Reporting Other Adverse Events: 5%. Full information can be found in the adverse events section. Summary can be found below.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Effect of a 128-day Supplementation on Weight</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Effect of a 128-day Supplementation on Weight</title>
          <population>Intent to treat population</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="2.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Effect of a 128-day Supplementation on Blood Pressure</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo)</title>
            <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Effect of a 128-day Supplementation on Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.37" spread="8.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" spread="7.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Effect of a 128-day Supplementation on Heart Rate</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Effect of a 128-day Supplementation on Heart Rate</title>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="16.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Effect of a 128-day Supplementation on Waist Circumference</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Effect of a 128-day Supplementation on Waist Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.86" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Effect of a 128-day Supplementation on Hip Circumference</title>
        <time_frame>Baseline (Day 0) to end-of-study (Day 128)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Salmon Protein Hydrolysate (CollaGo®)</title>
            <description>Dose: 1 sachet of CollaGo® will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
          </group>
        </group_list>
        <measure>
          <title>The Effect of a 128-day Supplementation on Hip Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.48" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>128-days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Salmon Protein Hydrolysate (CollaGo)</title>
          <description>Dose: 1 sachet of CollaGo will be mixed with 100-300 mL of water and consumed daily at breakfast.
Salmon Protein Hydrolysate: 4g of salmon protein hydrolysate per serving.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Mental breakdown</sub_title>
                <description>Determined to not be related to the study product</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back, muscle, leg pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neuropathy, paresthesia, tension headache</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The study was conducted by a contract research organization (CRO) of which the PI is a contract employee. The agreement between the CRO and sponsor indicates that all rights to discuss and publish the trial results belong to the sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Mal Evans</name_or_title>
      <organization>KGK Science Inc.</organization>
      <phone>519-438-9374</phone>
      <email>mevans@kgkscience.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

